ARMP: Armata Pharmaceuticals Inc Price-to-Revenue Ratio

Symbol and logo of brand Armata Pharma (ARMP)

The calculated price-to-sales ratio reflects the dynamics of a patent-protected ecosystem of precision antimicrobial agents. The value 24.90 represents the current level of the metric, helping to assess overbought risks. Armata Pharmaceuticals (ARMP) is developing phage therapy for the lungs through collaborations with medical centers. Its status as a recognized expert in the fight against superbugs provides the brand with high credibility among investors and scientists.

ARMP Armata Pharmaceuticals, Inc. Price-to-Revenue Ratio (07/04/2022 - 11/13/2026)

Metric breakdowns and analytics for Armata Pharma (ARMP)

- current quotes and average value forecast:
Market Price armatapharma.com|ARMP - Analyst Consensus Forecast
- market capitalization information:
Market Value Armata Pharma|ARMP - Enterprise Value
- issuer book value statistics:
Net Asset Value per Share Armata Pharmaceuticals|ARMP - Company Book Value|Market Capitalization to Book Value armatapharma.com|ARMP - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Armata Pharmaceuticals|ARMP - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Armata|ARMP - Company Debts|Debt to Book Value Armata Pharma|ARMP - Company Long-Term Debts|Company Short-Term Debts Armata Pharmaceuticals|Intermediate Liquidity Ratio armatapharma.com
- earnings and multiples data:
ARMP - Net Profit|Projected Future Earnings Armata Pharmaceuticals|ARMP - Price to Earnings Ratio|Future Price to Earnings Multiple Armata Pharmaceuticals Inc|ARMP - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio Armata Pharma|ARMP - Operating profit EBITDA|Earnings per share for the trailing year Armata Pharmaceuticals|ARMP - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth armatapharma.com|ARMP - Earnings per share growth in current year|Expected earnings per share trend next year Armata Pharmaceuticals
- total revenue and sales volume data:
ARMP - Company Revenue|Company Future Sales Volume armatapharma.com|ARMP - P/S Multiple|Forward P/S Multiple Armata Pharma
Fundamental company analysis:ARMP (armatapharma.com)
Signature product of Armata

For the biotech startup Armata Pharmaceuticals (ARMP), which has no commercial sales, the price-to-sales multiple loses its classical meaning due to the absence of revenue. This indicator compares market capitalization with sales volume to reflect the cost per unit of sales; however, with zero income and a high cash burn rate, this chart signals a speculative valuation and significant bankruptcy risks.

Competing companies

ACXP - Price to Sales